FDA Will Summarily Deny Petitions Submitted Solely To Block ANDA Approvals
Blocking generic competition by using citizen petitions to delay abbreviated new drug application approvals just got harder, under an FDA draft guidance released Jan. 16
Blocking generic competition by using citizen petitions to delay abbreviated new drug application approvals just got harder, under an FDA draft guidance released Jan. 16